Indo-Bangla Pharmaceuticals Limited

DSE:IBP Stock Report

Market Cap: ৳1.1b

Indo-Bangla Pharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

Indo-Bangla Pharmaceuticals is a dividend paying company with a current yield of 0.11%. Next payment date is on 26th January, 2025 with an ex-dividend date of 4th December, 2024.

Key information

0.1%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growth-63.6%
Next dividend pay date26 Jan 25
Ex dividend date04 Dec 24
Dividend per share৳0.010
Payout ratio-3%

Recent dividend and buyback updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: IBP is not paying a notable dividend for the BD market, therefore no need to check if payments are stable.

Growing Dividend: IBP is not paying a notable dividend for the BD market, therefore no need to check if payments are increasing.

Dividend Yield vs Market

Indo-Bangla Pharmaceuticals Dividend Yield vs Market
How does IBP dividend yield compare to the market?
SegmentDividend Yield
Company (IBP)0.1%
Market Bottom 25% (BD)1.1%
Market Top 25% (BD)4.5%
Industry Average (Pharmaceuticals)3.7%
Analyst forecast (IBP) (up to 3 years)n/a

Notable Dividend: IBP's dividend (0.11%) isn’t notable compared to the bottom 25% of dividend payers in the BD market (1.05%).

High Dividend: IBP's dividend (0.11%) is low compared to the top 25% of dividend payers in the BD market (4.54%).

Earnings Payout to Shareholders

Earnings Coverage: IBP is not paying a notable dividend for the BD market.

Cash Payout to Shareholders

Cash Flow Coverage: IBP is not paying a notable dividend for the BD market.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 03:33
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indo-Bangla Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution